On the other hand, if data comes back and things p
Post# of 148179
(Total Views: 486)
Posted On: 05/14/2020 11:17:55 AM
On the other hand, if data comes back and things play out the way everyone expects, in a few weeks the offering might be only 15million shares, or 10m, or possibly 5m... if the FDA isn't impressed with the results or slow-plays (again), then being on the NYSE won't mean so much, I don't think... that cash would be better used to ramp up production. JMO.
All uplisting will do is allow DIRECT institutional investment and give the SP a bump... I'm happy to buy every week at $3 so I'm in no rush for competition the likes of Goldman Sacs, etc.
All uplisting will do is allow DIRECT institutional investment and give the SP a bump... I'm happy to buy every week at $3 so I'm in no rush for competition the likes of Goldman Sacs, etc.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼